Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone
Phase of Trial: Phase II/III
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Somatropin (Primary)
- Indications Anorexia nervosa; Growth disorders
- Focus Therapeutic Use
- 14 Jan 2016 Planned end date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.
- 14 Jan 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.
- 23 Apr 2015 New trial record